Schroder Investment Management Group
CABA icon

Schroder Investment Management Group’s Cabaletta Bio CABA Stock Holding History

Schroder Investment Management Group’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66M Buy
856,637
+100,000
+13% +$329K ﹤0.01% 874
2026
Q1 		$1.87M Hold
756,637
– – ﹤0.01% 950
2025
Q4 		$1.63M Buy
+756,637
New +$1.88M ﹤0.01% 915

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Schroder Investment Management Group's CABA Position: Q2 2026 in Review

Schroder Investment Management Group increased its Cabaletta Bio (CABA) stake by 13% in Q2 2026, buying an estimated $329K and bringing the position to 856,637 shares worth $2.66M. The position accounts for ﹤0.01% of the portfolio, ranked #874.

Schroder Investment Management Group first reported a position in CABA in Q4 2025 and has held it in 3 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Schroder Investment Management Group held 856,637 shares of Cabaletta Bio worth $2.66M as of Q2 2026.
  • Schroder Investment Management Group bought 100,000 Cabaletta Bio shares in Q2 2026, an estimated $329K.
  • Cabaletta Bio made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #874 holding.
  • Schroder Investment Management Group first reported a position in Cabaletta Bio in Q4 2025 and has held it in 3 quarters since.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.